(Q39443782)

English

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

author name string

Zhi-Qiang Ning

1

1 reference

Europe PubMed Central

12 September 2017

Zhi-Bin Li

2

1 reference

Europe PubMed Central

12 September 2017

Michael J Newman

3

1 reference

Europe PubMed Central

12 September 2017

Song Shan

4

1 reference

Europe PubMed Central

12 September 2017

Xin-Hao Wang

5

1 reference

Europe PubMed Central

12 September 2017

De-Si Pan

6

1 reference

Europe PubMed Central

12 September 2017

Jin Zhang

7

1 reference

Europe PubMed Central

12 September 2017

Mei Dong

8

1 reference

Europe PubMed Central

12 September 2017

Xin Du

9

1 reference

Europe PubMed Central

12 September 2017

Xian-Ping Lu

10

1 reference

Europe PubMed Central

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 November 2011

1 reference

Europe PubMed Central

12 September 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

12 September 2017

69

1 reference

Europe PubMed Central

12 September 2017

4

1 reference

Europe PubMed Central

12 September 2017

901-909

1 reference

Europe PubMed Central

12 September 2017

https://scigraph.springernature.com/pub.10.1007/s00280-011-1766-x

0 references

Histone modifications as key regulators of transcription

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

The promises and pitfalls of epigenetic therapies in solid tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Histone deacetylase inhibitors: from bench to clinic

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Identification of type-specific anticancer histone deacetylase inhibitors: road to success

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Quantitative structure-activity relationship study of histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

MS-275, a potent orally available inhibitor of histone deacetylases--the development of an anticancer agent

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Development of a PAN-specific, affinity-purified anti-acetylated lysine antibody for detection, identification, isolation, and intracellular localization of acetylated protein

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1766-X

21 January 2018

Identifiers

10.1007/S00280-011-1766-X

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39443782&oldid=1828509685"